Lv1
10 积分 2025-09-23 加入
An updated patent review of BRD4 degraders
1天前
已完结
PROTACs in Treatment of Cancer: A Review
18天前
已完结
An updated patent review of SOS1 inhibitors (2022–present)
27天前
已完结
Abstract 2080: SOS1 inhibition is an effective therapeutic strategy in SOS1-mutant cancer
27天前
已完结
Abstract 1715: SOS1 inhibition is an effective therapeutic strategy in SOS1-mutant cancer
2个月前
已关闭
Targeting RAS oncogenesis with SOS1 inhibitors
2个月前
已完结
Targeting RAS oncogenesis with SOS1 inhibitors
2个月前
已关闭
Regulation of B-cell fate by antigen-receptor signals
2个月前
已完结
PRN2246, a potent and selective blood brain barrier penetrating BTK inhibitor, exhibits efficacy in central nervous system immunity
3个月前
已关闭
ABBV-105, a selective and irreversible inhibitor of Bruton’s tyrosine kinase, is efficacious in multiple preclinical models of inflammation
3个月前
已完结
皖公网安备34019202002308
